RVL Pharmaceuticals Has Been Considering Certain Strategic Alternatives, Including Discussions To Acquire A Specific Potential Counterparty In An All-stock Strategic Deal And Discussions With Potential Financing Sources For The Combined Company
Portfolio Pulse from Benzinga Newsdesk
RVL Pharmaceuticals is considering strategic alternatives, including acquiring a specific potential counterparty in an all-stock deal. The company is also in discussions with potential financing sources for the combined company and is in business development discussions with other parties.
July 05, 2023 | 10:54 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
RVL Pharmaceuticals is considering strategic alternatives, which could potentially lead to an all-stock acquisition. This could impact the company's stock price.
The news of RVL Pharmaceuticals considering strategic alternatives, including an all-stock acquisition, could potentially impact the company's stock price. However, the impact is uncertain as it depends on the specifics of the deal and the market's reaction to it.
CONFIDENCE 70
IMPORTANCE 80
RELEVANCE 100